NCT05557162 - Artificial Intelligence Enhanced ECG to Detect Cardiac Amyloidosis | Biotech Hunter

Enrollment

20,143

Participants

Timeline

Start Date

June 19, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Cardiac Amyloidosis

Interventions

OTHER

AI ECG Amyloid algorithm

Artificial intelligence enabled electrocardiogram screening tool used to identify the predictive model that best differentiates those at greatest risk for an amyloidosis diagnosis

Trial Locations (4)

32224

Mayo Clinic in Florida, Jacksonville

54701

Mayo Clinic Health System - Eau Claire, Eau Claire

55905

Mayo Clinic in Rochester, Rochester

85259

Mayo Clinic in Arizona, Scottsdale